Research profile · Nootropics
Modafinil
Wakefulness-promoting agent
Available as: 10g
Overview
A eugeroic approved in many countries for narcolepsy, shift-work sleep disorder and obstructive sleep apnoea. It is a controlled or prescription-only substance in many jurisdictions.
Mechanism
Weakly inhibits the dopamine transporter and influences orexin, histamine and noradrenaline systems.
Research highlights
- Improves wakefulness in sleep-disorder trials.
- Studied for effects on attention and executive function.
Compound data
- Type
- Small molecule